BRC News

BRC-supported researchers are among many UCL academics named in the internationally recognised Clarivate listings.

A new daily pill has shown continuous, round-the-clock control of high blood pressure in people whose condition is difficult to manage.

Major UCL-led study finds that sertraline, one of the most commonly prescribed antidepressants, improves core symptoms of depression such as low mood and suicidal thoughts within two weeks.

The global study is taking place in 18 countries.

A patient with motor neurone disease was able to control a computer just by using his thoughts following the surgery at UCLH.

With CAR T cell therapy proven to be effective in blood cancer patients, researchers are turning to testing the treatment in autoimmune conditions such as lupus and now MS.

The £26 million project is accelerating the search for effective treatments.

A study shows it is possible to cut the time for diagnostic MRI scans for dementia to one third of their standard length.

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial.

UCLH has produced a short video to support members of Black communities who may be considering taking part in health research.

The study is BRC supported and took place at the NIHR UCLH Clinical Research Facility.

Three BRC-supported clinicians at UCL and UCLH contributed to the analysis.

The CCTU who won the award at the UCLH Celebrating Excellence Awards 2025.

A quicker, cheaper MRI scan has been shown to be as accurate at diagnosing prostate cancer as the current 30-40 minute scan.

The results suggest the tool could reduce unplanned ICU admissions after surgery tenfold.